Trial ID or NCT#
This study involves the treatment of cognitive impairment secondary to moderate to severe brain injury using central thalamic deep brain stimulation. Although all patients will receive stimulation continuously through a surgically implanted pacemaker-like device, half of the patients will have the device deactivated during a blinded assessment phase. The device will be reactivated following this assessment and patients will have the option to continue stimulation in an open-label continuation.
CT-DBS for Traumatic Brain Injury Using the Medtronic Activa PC+S System
Contact us to find out if this trial is right for you.
Jaimie M Henderson, MD